This is the protocol for a review and there is no abstract. The objectives are as follows:
By meta-analysis and systematic review of RCTs, to evaluate the role of prokinetics in the treatment of FD as reflected by improvement of either individual or global dyspepsia symptom scores and quality of life scores. The primary comparisons will be as follows.
Are prokinetic drugs in general better than placebo?
Which of the individual prokinetic drugs is the most effective?